SLC39A8 and inflammatory bowel disease: The finding of higher expression levels of Acer1 in the ileum and colon (Fig. 6) led us to test the contribution of ACER1 to the impaired intestinal barrier function and IBD susceptibility of Slc39a8-IEC KO mice.